Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.18 -0.78 (-1.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Cash from Discontinued Operations (2013)

Updated

Ani Pharmaceuticals (ANIP) recorded Cash from Discontinued Operations of $44,000 in Q4 2013.

Analysis

Ani Pharmaceuticals (ANIP) Cash from Discontinued Operations (2013) Analysis & Trends

For FY2013, Ani Pharmaceuticals reported Cash from Discontinued Operations of -$195,000.

  • Across earlier years, Cash from Discontinued Operations came in at -$300,000 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Ani Pharmaceuticals 1.72 Bn 502.13 Mn 165.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 44,000.00
Sep 30, 2013 -234,624.00
API Access

Ani Pharmaceuticals Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=ANIP&period=max&api_key=YOUR_API_KEY